- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 20th, 2007
Poor solubility of cancer drugs as well as the toxicity induced by solvents have dogged cancer therapy. But now, a new study suggests that nanomaterials may be the solution.
Today there are many anticancer drugs in the market, which have been recommended at different stages. Camptothecin is the one of the important anticancer drug available in the market.
|Related News Press|
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016
Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016
Nanotechnology Treatment Found to Inhibit Mesothelioma Tumor Growth November 16th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Quantum obstacle course changes material from superconductor to insulator December 1st, 2016
Throwing new light on printed organic solar cells December 1st, 2016